Project Grant RF1NS127266
- Federal Grant Award Summary The National Institute on Aging (NIA) awarded a $3.52 million Project Grant to the University of California, Davis, under the Aging Research program (CFDA 93.866) to conduct longitudinal magnetic resonance imaging (MRI) studies examining cerebrovascular injury and Alzheimer's disease atrophy in Latino populations. The award, obligated on March 15, 2026, with a completion date of November 30, 2030, funds the continuation phase of the "Longitudinal MRI Measures...
- This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $460,844 to The Trustees of Columbia University in the City of New York to conduct the "LIFE-COURSE ACCULTURATION TRAJECTORIES AND DEMENTIA IN A MULTI-ETHNIC COHORT OF OLDER ADULTS: THE MESA ACCULTURATION AND DEMENTIA STUDY". The study aims to leverage longitudinal data from the Multi-Ethnic Study of Atherosclerosis (MESA) to identify unique life-course acculturation patterns among...
- The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $4,390,219 Project Grant under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) to the Regents of the University of Minnesota, Office of Sponsored Projects Administration. The 3-year project aims to determine the prognostic importance of atrial myopathy for incident dementia in the oldest-old population, relate atrial myopathy progression to cognitive decline and...
- CONNECT-AD Study: Summary of Grant Products and Services The National Institute on Aging (NIA) awarded the University of California, Los Angeles a $534,287 Project Grant on September 30, 2025, under the Aging Research program (CFDA 93.866) to develop and deliver research products addressing care coordination challenges in Alzheimer's disease and related dementias. The primary deliverable is the creation of the first multisite electronic health record (EHR) communication database incorporating...
- This Project Grant award of $353,391.00, provided by the National Institute on Aging (CFDA 93.866 - Aging Research), aims to validate the use of a "Personal Learning Curve" paradigm as a sensitive marker of early memory decline related to Alzheimer's disease (AD) biomarkers in a large, diverse sample of older adults. The study seeks to determine if this digital cognitive assessment tool, which measures learning over repeated evaluations, can detect subtle AD-related memory failures...
- This Project Grant award, valued at $2,380,018.00, was provided by the National Institute on Aging (CFDA 93.866 - Aging Research) to the Regents of the University of Michigan. The overarching goal is to investigate the influence of cumulative hyperglycemia, type 2 diabetes management, and vascular risk factors on cognitive decline and Alzheimer's disease and related dementias (ADRD) risk. The research team will leverage pooled cohort studies and individual participant data meta-analysis to...
- Award Summary The National Institute on Aging awarded Brigham and Women's Hospital a $7.42 million Cooperative Agreement under the Aging Research program (CFDA 93.866) effective July 1, 2025, through June 30, 2030, to develop the Precision-AD Center. This initiative will establish a toolkit of two-dimensional and three-dimensional microphysiological systems (MPS) designed to model Alzheimer's disease and related dementias across genetically diverse populations. The project leverages induced...
- The National Institute on Aging (NIA) awarded a $454,024 Project Grant (CFDA 93.866 - Aging Research) to the Research Foundation For Mental Hygiene, Inc. (RFMH) to conduct research on high-frequency oscillations (HFOs) as a potential biomarker for Alzheimer's disease progression. The key goals of this 2-year project are to: (1) determine if HFOs originate in the hippocampus and expand to other brain regions as Alzheimer's pathology advances, (2) assess whether disrupting HFOs can improve...
- This Project Grant award of $4,787,820.00 from the National Institute on Aging (CFDA 93.866 - Aging Research) aims to gain a better understanding of the individual- and system-level characteristics that influence diagnosis of mild cognitive impairment (MCI) and Alzheimer's disease and related dementias (ADRD), and how diagnosis can moderate the effects of cognitive decline on employment, future care, and quality of life. The key objectives are to: 1) examine whether older adults experiencing...
- This $1,933,556 Project Grant awarded by the National Institute on Aging (NIA) under its Aging Research program (CFDA 93.866) will support research to assess the impact of hospital-based health information technology (hospital-HIT) on healthcare quality and equity for patients with Alzheimer's disease and related dementias (ADRD). The primary awardee, the University of Maryland, College Park, will conduct a ten-year longitudinal study to evaluate how hospital-HIT systems that promote care...
COGNITIVE AGING, BRAIN MORPHOLOGY, AND ARRHYTHMIAS IN HISPANICS/LATINOS: IMPLICATIONS FOR PREVENTION AND MANAGEMENT OF ALZHEIMER'S DISEASE-RELATED DEMENTIAS - ALZHEIMER'S DISEASE (AD) AND AD-RELATED DEMENTIAS (ADRD) ARE PROJECTED TO AFFECT 115 MILLION PEOPLE WORLDWIDE BY 2050. VASCULAR CONTRIBUTIONS TO COGNITIVE IMPAIRMENT AND DEMENTIA (VCID)-A PRIMARY TYPE OF ADRD-IS A MAJOR RESEARCH FOCUS FOR THE NIH, WHICH HAS CALLED FOR THE NEED FOR STUDIES OF PREVENTION ACROSS THE LIFESPAN AND IN DIVERSE POPULATIONS (ADRD SUMMIT 2019). UNDERRECOGNIZED BUT RELEVANT TO VCID, PRIOR RESEARCH INDICATES THAT ARRHYTHMIAS ARE ASSOCIATED WITH LOWER COGNITIVE FUNCTION AND GREATER RISK OF AD/ADRD. HOWEVER, CURRENT KNOWLEDGE OF ARRHYTHMIAS' NEUROCOGNITIVE IMPACT IS LACKING IN THE FASTEST GROWING ETHNIC GROUP IN THE USA-HISPANICS/LATINOS-WHO ARE ANTICIPATED TO CONTRIBUTE DISPROPORTIONATELY TO THE PROJECTED INCREASE IN PREVALENCE OF MILD COGNITIVE IMPAIRMENT (MCI) AND ADRD. THUS, ROBUST AND COMPREHENSIVE DATA ON PREVALENCE AND NEUROCOGNITIVE IMPACT OF ARRHYTHMIAS IN HISPANICS/LATINOS ARE CRITICALLY NEEDED. FURTHERMORE, FROM A PREVENTION STANDPOINT, ALTHOUGH PRIOR RESEARCH SHOWS THAT MODIFIABLE LIFESTYLE AND CARDIOVASCULAR DISEASE (CVD) RISK FACTORS ARE RELATED TO ADRD RISK AND ARRHYTHMIA RISK AND BURDEN, IT IS UNKNOWN WHETHER OPTIMIZING LIFESTYLE/CVD RISK FACTORS CAN MITIGATE THE ARRHYTHMIA-ADRD RELATIONSHIP. TO ADDRESS THE FOREGOING KNOWLEDGE GAPS, WE WILL APPLY THE ZIOXT PATCH-A NON-INVASIVE AMBULATORY CONTINUOUS ECG MONITOR-TO ~5,000 PARTICIPANTS (AGE =45 YEARS) IN THE HISPANIC COMMUNITY HEALTH STUDY/STUDY OF LATINOS (HCHS/SOL) IN 2022-24 (CONCURRENT WITH VISIT 3) AND LEVERAGE THE RICH DATA IN HCHS/SOL AND RELATED ANCILLARY STUDIES: NEUROCOGNITIVE ASSESSMENT, ADJUDICATED MCI AND ADRD, BRAIN MRI, CARDIAC MRI, LIFESTYLE/CVD RISK FACTORS INCLUDING 7-DAY ACCELEROMETER-BASED PHYSICAL ACTIVITY, ADIPOSITY MEASURES, AND BLOOD PRESSURE. WE HYPOTHESIZE THAT IN HISPANIC/LATINO ADULTS, HIGHER ARRHYTHMIA FREQUENCY WILL BE ASSOCIATED WITH HIGHER INCIDENCE OF MCI OR ADRD, GREATER COGNITIVE DECLINE, MORE BRAIN INFARCTS AND SMALL VESSEL ISCHEMIC DISEASE, AND LOWER BRAIN VOLUMES. THESE ASSOCIATIONS WILL BE INDEPENDENT OF CVD AND CARDIAC STRUCTURE/FUNCTION AND WILL BE MORE EVIDENT IN THOSE WITH LESS OPTIMAL (VS. MORE OPTIMAL) LIFESTYLE/CVD RISK FACTOR TRAJECTORIES. WE WILL EVALUATE THESE AIMS: AIM 1: DEFINE THE PREVALENCE AND FREQUENCY OF ARRHYTHMIAS IN HISPANIC/LATINO ADULTS USING AMBULATORY HEART RHYTHM MONITORING, AIM 2: EVALUATE THE ASSOCIATION OF ARRHYTHMIAS WITH CHANGE IN COGNITIVE FUNCTION AND INCIDENT MCI OR ADRD, AIM 3: ASSESS THE ASSOCIATION OF ARRHYTHMIAS WITH MARKERS OF VASCULAR BRAIN INJURY BASED ON BRAIN MRI. IMPORTANTLY, FOR EACH AIM, WE WILL EXAMINE THE CONSISTENCY OF ASSOCIATIONS BY ANTECEDENT 10-YEAR LIFESTYLE/CVD RISK FACTOR TRAJECTORIES. THIS PROJECT WILL COMBINE EXCEPTIONAL AND COMPLEMENTARY SCIENTIFIC EXPERTISE, WEARABLE AND IMAGING TECHNOLOGY, RIGOROUS EPIDEMIOLOGICAL AND ANALYTICAL METHODS, AND LEVERAGE AN EXISTING NIH COHORT TO REFINE THE VCID PARADIGM AND OVERCOME CRITICAL BARRIERS IN AD/ADRD AND MINORITY HEALTH RESEARCH, THUS ACHIEVING A SUSTAINED AND POWERFUL IMPACT ON PUBLIC HEALTH AND CLINICAL PRACTICE.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $765.0k | 8/4/25 | ||
| Not listed | ($765k) | 8/4/25 | ||
| Not listed | $4.1m | 3/18/22 |
GrantNumber | Description | Subgrantee | Prime Award | Dollars Obligated | Updated At |
|---|---|---|---|---|---|
N009539504S | Albert Einstein College Of Medicine | Project Grant RF1NS127266 | $291.2k | 10/13/23 | |
N009539502S | The Johns Hopkins University | Project Grant RF1NS127266 | $157.9k | 10/10/23 | |
N009539503S | University Of Miami | Project Grant RF1NS127266 | $205.8k | 10/8/23 | |
N009539506S | University Of Illinois | Project Grant RF1NS127266 | $302.6k | 9/25/23 | |
N009539501S | University Of California, San Diego | Project Grant RF1NS127266 | $199.2k | 9/13/23 |